STA-9090(Ganetespib) in Patients With Unresectable Stage III or Stage IV Melanoma

NCT01551693 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
3
Enrollment
OTHER
Sponsor class

Stopped due to weak accrual

Conditions

Interventions

Sponsor

Dana-Farber Cancer Institute

Collaborators